NCT04986176View on ClinicalTrials.gov

HC-1119 Adjuvant Treatment for Hospitalized COVID-19 Patients

PHASE3UnknownINTERVENTIONAL
Enrollment

602

Participants

Timeline

Start Date

April 15, 2022

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
COVID-19 Respiratory Infection
Interventions
DRUG

HC-1119

oral

DRUG

Placebo

oral

Sponsors
All Listed Sponsors
collaborator

Hinova Pharmaceuticals Inc.

INDUSTRY

lead

Applied Biology, Inc.

INDUSTRY